Key Takeaways
European Wax Center, Inc. (NASDAQ: EWCZ) is currently navigating a pivotal transition, with the company announcing on February 10, 2026, that it has entered into a definitive agreement to be taken private by General Atlantic. This all-cash transaction values EWCZ at an implied equity value of approximately $330 million, with shareholders (excluding General Atlantic affiliates) slated to receive $5.80 per share. Once the deal closes, expected in mid-2026, EWCZ's Class A common stock will cease to be publicly listed, and the company will operate as a privately held entity.
This move marks a significant shift for the beauty services franchisor, which operates a network of over 1,000 locations across the United States. General Atlantic, already a substantial investor with approximately 42% beneficial ownership, is acquiring the remaining outstanding shares. The offer price of $5.80 represents a 45% premium to EWCZ's closing stock price on February 9, 2026, the day prior to the announcement, and a 51% premium to its 90-day volume-weighted average share price.
However, the proposed buyout has not been met with universal approval, particularly from a shareholder perspective. Kaskela Law LLC has launched an investigation into the fairness of the $5.80 per share offer, raising concerns that the price may undervalue the company. This legal scrutiny introduces a layer of uncertainty for investors, who are now prompted to evaluate whether the current offer provides sufficient financial consideration for their shares.
The core of the investigation stems from the disparity between the buyout price and certain analyst projections. At the time of the announcement, at least one analyst maintained a price target of $15.00 per share for EWCZ, a figure more than 150% higher than the agreed-upon acquisition price. This significant gap suggests that some market participants believe EWCZ's intrinsic value far exceeds what General Atlantic is offering, setting the stage for potential shareholder dissent and a re-evaluation of the deal terms.
The question of fairness surrounding the $5.80 per share buyout price for European Wax Center is central to the ongoing shareholder investigation. While the offer represents a substantial premium over EWCZ's pre-announcement trading levels, it falls considerably short of some analyst expectations, creating a clear point of contention. Specifically, the $15.00 per share high price target from Morgan Stanley's Simeon Gutman, representing a potential 159.5% upside from the current trading price of $5.74, stands in stark contrast to the acquisition terms.
Wall Street's consensus on EWCZ has been largely "Hold," with a median price target of $5.80 from eight analysts. This median target aligns precisely with the buyout price, suggesting that for many analysts, the offer is indeed fair given the company's current trajectory and market conditions. However, the existence of a significantly higher target, even if an outlier, provides ammunition for those arguing the company is undervalued. The current stock price of $5.74 trades just below the offer, indicating the market largely expects the deal to close at the proposed price, with minimal arbitrage opportunity.
Consider the company's 52-week trading range, which saw shares fluctuate between a low of $2.95 and a high of $6.51. The $5.80 offer sits comfortably above the 52-week low, but notably below the 52-week high, which was reached relatively recently. This suggests that at certain points, the market itself valued EWCZ shares higher than the current buyout offer. The premium offered by General Atlantic, while significant against recent averages, might not fully capture the company's peak market valuation or its long-term growth potential as envisioned by more bullish analysts.
The Special Committee of independent directors unanimously approved the transaction, advised by Moelis & Company LLC. This committee's role is to ensure the deal is in the best interest of public shareholders. However, the Kaskela Law investigation will likely scrutinize the process and the financial analyses that led to this recommendation, particularly in light of the divergent analyst opinions. Shareholders are left to reconcile the immediate premium with the possibility that EWCZ, under different circumstances or with a different valuation approach, could be worth considerably more.
A deeper dive into European Wax Center's financial performance reveals a mixed picture that could influence the debate over the $5.80 per share buyout price. For the trailing twelve months (TTM), EWCZ reported a market capitalization of $313.0 million and an Enterprise Value (EV) of $619.3 million. Key valuation multiples include a P/E ratio of 28.96, P/S of 1.52, and EV/EBITDA of 9.75. These metrics provide a snapshot of how the company is valued relative to its earnings, sales, and operational cash flow.
Recent earnings reports have shown some headwinds. In fiscal 2025 Q4, announced on March 4, 2026, EWCZ reported an EPS of $0.10, which beat the Zacks Consensus Estimate of $0.04. However, this was a decline from $0.16 per share a year ago. Revenue for the quarter was $45.1 million, missing the consensus estimate by 0.88% and down from $49.74 million in the prior-year period. Another report indicated a net loss of $1.46 million for Q4 2025, a significant deterioration from a $3.07 million net income in Q4 2024, with revenue dropping 8.9% to $42.30 million.
Looking at the full fiscal year 2025, EWCZ's revenue declined 4.7% to $206.6 million, and adjusted EBITDA was down 3.0% to $73.3 million. The company also saw a 1.9% decrease in total centers, indicating some franchise closures, although same-store sales showed a modest 0.2% increase. These figures suggest operational challenges and a weakening franchise health, which could justify a more conservative buyout valuation.
Despite these challenges, EWCZ boasts strong margins for the TTM, with a gross margin of 73.9% and an operating margin of 20.9%. Its Free Cash Flow (FCF) yield stands at a healthy 16.0%, with TTM FCF per share at $1.14. The company also ended the year with $76.1 million in cash. While profitability has been under pressure, the underlying business model, focused on recurring waxing services and proprietary product sales, has historically generated strong cash flows. The question for shareholders is whether the $5.80 offer adequately captures the value of these assets and the potential for future recovery or growth under private ownership.
General Atlantic's decision to take European Wax Center private at $5.80 per share is likely driven by a combination of strategic factors, including the desire for greater operational control, the ability to make long-term investments away from public market scrutiny, and a belief in the brand's underlying value despite recent headwinds. As a leading global investor and already a significant shareholder with 42% of EWCZ's outstanding shares, General Atlantic possesses deep familiarity with the company's business model and growth prospects.
Private ownership offers distinct advantages. EWCZ, as a public company, has faced pressure to meet quarterly earnings expectations and navigate market sentiment, which can sometimes conflict with long-term strategic initiatives. For instance, the company's CEO highlighted "strategic investments in headcount" to support growth, which led to a 4.3% rise in SG&A expenses. Such investments, while crucial for future expansion, can temporarily depress reported earnings and be met with skepticism by public markets focused on short-term results.
Under private ownership, General Atlantic can implement operational changes, invest in new initiatives, or restructure the business without the constant pressure of public reporting or shareholder activism. This flexibility is particularly valuable given the reported challenges, such as the 1.9% decrease in total centers and the 4.7% decline in fiscal 2025 revenue. A private equity firm can focus on stabilizing the franchise system, optimizing profitability, and pursuing growth strategies that may take several years to mature, without the need to justify every quarter's performance to the Street.
Furthermore, the $5.80 offer, while contested by some, provides General Atlantic with an opportunity to acquire the remaining shares at a price that reflects a premium over recent trading but potentially undervalues the company's long-term potential in their view. The firm's long-standing relationship with EWCZ, dating back to its initial investment in 2018, suggests a deep understanding of the business and a conviction that they can unlock greater value outside the public eye. This move allows General Atlantic to fully capitalize on EWCZ's brand leadership in the waxing industry, its proprietary Comfort Wax® technology, and its recurring revenue model, free from the constraints of public market dynamics.
For European Wax Center shareholders, the announcement of the $5.80 per share buyout by General Atlantic presents a critical juncture, demanding a careful evaluation of their options. The most straightforward path is to accept the offer. With the current stock price of $5.74 trading just below the offer price, selling shares on the open market or tendering them in the eventual acquisition provides a near-certain cash return, albeit a modest 0.3% upside from the current market price. This option offers liquidity and eliminates further market risk associated with the company.
However, the ongoing investigation by Kaskela Law LLC introduces another dimension. Shareholders who believe the $5.80 offer undervalues their investment have the option to explore legal avenues. This typically involves contacting the law firm to understand their rights and potentially participate in a class action or similar legal challenge. The goal of such actions is to compel General Atlantic or EWCZ's board to increase the buyout price, arguing that the current offer does not provide sufficient financial consideration, especially in light of the $15.00 analyst price target.
Holding shares through the closing of the transaction is also an option, which would result in shareholders being cashed out at the $5.80 per share price. However, this carries the risk that the deal could fall through due to regulatory hurdles, failure to secure shareholder approval, or other unforeseen circumstances. If the deal collapses, EWCZ's stock price would likely revert to its pre-announcement levels, which could be significantly lower than the offer price, potentially leading to losses for those who held on.
Ultimately, the decision hinges on an individual investor's risk tolerance and conviction regarding EWCZ's true value. Accepting the $5.80 offers immediate, guaranteed cash. Pursuing legal action, while potentially leading to a higher payout, involves uncertainty, time, and no guarantee of success. Given the company's recent financial performance, including declining revenue and a net loss in Q4 2025, some investors may prefer the certainty of the current offer, while others might view the $15.00 analyst target as a compelling reason to push for more.
The path forward for European Wax Center and its investors is now largely defined by the pending privatization. Shareholders must weigh the immediate, guaranteed cash offer against the potential for a higher valuation, a decision complicated by both the company's recent financial performance and the ongoing legal scrutiny. The outcome of Kaskela Law's investigation will be a key factor for those considering whether to challenge the $5.80 price.
For those seeking to maximize their return, engaging with the legal process or simply holding shares in anticipation of a revised offer might be appealing, though it carries inherent risks. Conversely, accepting the current offer provides a clear exit strategy and avoids further market volatility or the uncertainty of a protracted legal battle. The market's current pricing of EWCZ shares at $5.74 suggests a high probability of the deal closing as announced.
EWCZ's journey as a public company is nearing its end, marking a new chapter under private ownership where General Atlantic will have the autonomy to reshape its strategy. For investors, the focus shifts from quarterly earnings to the finalization of the deal and, for some, the pursuit of a more equitable return on their investment.
Want deeper research on any stock? Try Kavout Pro for AI-powered analysis, smart signals, and more. Already a member? Add credits to run more research.
